Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0001045969-98-000324
Filing Date
1998-03-31
Accepted
1998-03-31 00:00:00
Documents
7
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 10-K405 136736
2 SUPPLY AND LICENSE AGREEMENT EX-10.23 46846
3 COMPUTATION OF NET LOSS PER COMMON SHARE EX-11 1090
4 INDEPENDENT AUDITORS CONSENT EX-23 946
5 POWER OF ATTORNEY EX-24 2251
6 FINANCIAL DATA SCHEDULE EX-27 2377
7 CAUTIONARY STATEMENTS EX-99 20226
  Complete submission text file 0001045969-98-000324.txt   212696
Mailing Address OPUS CENTER 9900 BREN ROAD EAST SUITE 300E MINNEAPOLIS MN 55343
Business Address 9900 BREN RD EAST STE 300E C/O OPUS CENTER MINNETONKA MINNESOTA MINNEAPOLIS MN 55343 6129357335
MGI PHARMA INC (Filer) CIK: 0000702131 (see all company filings)

EIN.: 411364647 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-10736 | Film No.: 98580153
SIC: 2834 Pharmaceutical Preparations